ProPhase Labs Discusses Milestones in Cancer Diagnostics and COVID Accounts Receivable Collection

lunes, 1 de diciembre de 2025, 8:05 pm ET1 min de lectura
PRPH--

ProPhase Labs, a biotech company, discusses its milestones in cancer diagnostics, genomics expansion, and COVID-19 accounts receivable collection. CEO Ted Karkus presents the company's progress and future plans, highlighting its focus on cancer diagnostics and genomics expansion.

ProPhase Labs Discusses Milestones in Cancer Diagnostics and COVID Accounts Receivable Collection

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios